Samantha K Kurosky

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Respiratory Tract

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Patient preference and adherence

Infectious diseases and therapy

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Adam M Brufsky, Martine C Maculaitis, Lewis Kopenhafer, Patrick Olsen, Samantha K Kurosky, Lillian Shahied Arruda, Wendy Heck, Ashley S Cha-Silva
Identifying drivers of first-line HR+/HER2- metastatic breast cancer treatment choices. Future oncology (London, England) (2024)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)
Mark H Rozenbaum, Jennifer Toolan Judy, Diana Tran, Kari Yacisin, Samantha K Kurosky, Elizabeth Begier
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States. Infectious diseases and therapy 12 (2) (2023)
Mark H Rozenbaum, Jennifer Toolan Judy, Diana Tran, Kari Yacisin, Samantha K Kurosky, Elizabeth Begier
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States. Infectious diseases and therapy (2023)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)
Mark H Rozenbaum, Jennifer Toolan Judy, Diana Tran, Kari Yacisin, Samantha K Kurosky, Elizabeth Begier
Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States. Infectious diseases and therapy (2023)
Nicole M Engel-Nitz, Mary G Johnson, Michael P Johnson, Ashley S Cha-Silva, Samantha K Kurosky, Xianchen Liu
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer. Patient preference and adherence 17 (2023)